X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (173271) 173271
Book / eBook (424) 424
Conference Proceeding (134) 134
Magazine Article (105) 105
Book Chapter (54) 54
Dissertation (35) 35
Web Resource (30) 30
Government Document (13) 13
Newsletter (7) 7
Book Review (6) 6
Publication (6) 6
Journal / eJournal (5) 5
Streaming Video (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143009) 143009
animals (75793) 75793
female (71283) 71283
oncology (69638) 69638
cancer (68279) 68279
male (50852) 50852
mice (47487) 47487
cell line, tumor (40132) 40132
middle aged (33413) 33413
research (32168) 32168
chemotherapy (28885) 28885
aged (28182) 28182
tumors (27645) 27645
apoptosis (26204) 26204
adult (24890) 24890
care and treatment (24856) 24856
expression (22845) 22845
medicine, research & experimental (22059) 22059
metastasis (21164) 21164
analysis (20306) 20306
breast cancer (18873) 18873
health aspects (18707) 18707
antineoplastic agents - therapeutic use (18020) 18020
antineoplastic agents - pharmacology (17867) 17867
neoplasms - drug therapy (15611) 15611
treatment outcome (15528) 15528
oncology, experimental (15369) 15369
pharmacology & pharmacy (15183) 15183
proteins (14897) 14897
gene expression (14815) 14815
cell biology (14741) 14741
prognosis (14705) 14705
therapy (14592) 14592
apoptosis - drug effects (14225) 14225
mice, nude (14201) 14201
cancer therapies (13694) 13694
cell proliferation - drug effects (13307) 13307
medicine & public health (13295) 13295
medicine (12820) 12820
biochemistry & molecular biology (12642) 12642
genetic aspects (12499) 12499
medical research (12471) 12471
research article (12009) 12009
cells (11772) 11772
survival (11538) 11538
growth (11283) 11283
carcinoma (11000) 11000
rats (10656) 10656
signal transduction (10648) 10648
development and progression (10601) 10601
breast-cancer (10519) 10519
aged, 80 and over (10461) 10461
mice, inbred balb c (10365) 10365
xenograft model antitumor assays (10303) 10303
breast neoplasms - drug therapy (10298) 10298
antineoplastic combined chemotherapy protocols - therapeutic use (10223) 10223
kinases (9762) 9762
gene expression regulation, neoplastic (9696) 9696
cell proliferation (9662) 9662
surgery (9530) 9530
tumor cells, cultured (9526) 9526
drug therapy (9494) 9494
breast neoplasms - pathology (9446) 9446
neoplasm transplantation (9400) 9400
multidisciplinary sciences (9383) 9383
dose-response relationship, drug (9170) 9170
angiogenesis (9049) 9049
cancer research (9034) 9034
activation (9018) 9018
mutation (8864) 8864
immunotherapy (8713) 8713
neoplasms, experimental - drug therapy (8676) 8676
in-vitro (8667) 8667
neoplasms - pathology (8636) 8636
risk factors (8521) 8521
studies (8502) 8502
inhibition (8243) 8243
cell survival - drug effects (8178) 8178
disease models, animal (8159) 8159
in-vivo (8056) 8056
patients (8003) 8003
colorectal cancer (7863) 7863
immunohistochemistry (7850) 7850
cell cycle (7818) 7818
neoplasms. tumors. oncology. including cancer and carcinogens (7758) 7758
physiological aspects (7693) 7693
lung neoplasms - drug therapy (7655) 7655
lung cancer (7607) 7607
biotechnology & applied microbiology (7551) 7551
biology (7528) 7528
medical prognosis (7461) 7461
time factors (7447) 7447
hematology (7420) 7420
hematology, oncology and palliative medicine (7351) 7351
neoplasm staging (7305) 7305
neoplasms - therapy (7251) 7251
radiotherapy (7199) 7199
prostate cancer (7172) 7172
clinical trials (7164) 7164
neoplasms - metabolism (7164) 7164
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (169) 169
Online Resources - Online (32) 32
Collection Dvlpm't (Acquisitions) - Vendor file (29) 29
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (23) 23
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
St. Michael's Hospital - Stacks (5) 5
New College (Ivey) - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Bindery (2) 2
Gerstein Science - Circulation Desk (2) 2
Gerstein Science - Periodical Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
UofT at Scarborough - Stacks (2) 2
Victoria University E.J. Pratt - Oversize (2) 2
Earth Sciences (Noranda) - Circulation Desk (1) 1
Earth Sciences (Noranda) - Oversize (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Processing (1) 1
Gerstein Science - Reserve desk (1) 1
Lakeridge Health Sciences - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mathematical Sciences - Stacks (1) 1
OISE - Stacks (1) 1
Physics - Course Reserves (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Circulation Desk (1) 1
Victoria University E.J. Pratt - Circulation Desk (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (171147) 171147
Japanese (1298) 1298
Russian (980) 980
German (627) 627
Chinese (594) 594
French (392) 392
Polish (133) 133
Italian (103) 103
Spanish (91) 91
Portuguese (26) 26
Hungarian (21) 21
Ukrainian (21) 21
Czech (17) 17
Korean (13) 13
Swedish (11) 11
Bulgarian (10) 10
Danish (10) 10
Romanian (10) 10
Croatian (7) 7
Norwegian (6) 6
Dutch (5) 5
Hebrew (5) 5
Serbian (5) 5
Slovak (4) 4
Turkish (4) 4
Arabic (3) 3
Lithuanian (3) 3
Finnish (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of experimental therapeutics & oncology, ISSN 1359-4117, 1996
Journal
American journal of clinical oncology: cancer clinical trials, ISSN 0277-3732, 1982
Journal
Nature (London), ISSN 1476-4687, 2015, Volume 520, Issue 7547, pp. 368 - 372
Drug resistance invariably limits the clinical efficacy of targeted therapy with kinase inhibitors against cancer(1,2... 
CNS CELL-TYPES | MELANOMA | METASTASIS | MICROENVIRONMENT | TRANSLATIONAL PROFILING APPROACH | MULTIDISCIPLINARY SCIENCES | RAF INHIBITOR RESISTANCE | ACQUIRED-RESISTANCE | KINASE INHIBITORS | DRUG-RESISTANCE | CANCER CHEMORESISTANCE | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Clone Cells - drug effects | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Proto-Oncogene Proteins c-fos - deficiency | Adenocarcinoma - metabolism | Anaplastic Lymphoma Kinase | Neoplasm Metastasis - drug therapy | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Proto-Oncogene Proteins c-akt - metabolism | Melanoma - metabolism | Tumor Microenvironment - drug effects | Cell Survival - drug effects | ErbB Receptors - antagonists & inhibitors | Melanoma - pathology | Down-Regulation - drug effects | Enzyme Activation - drug effects | Adenocarcinoma - drug therapy | Disease Progression | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Cell Movement - drug effects | Animals | Clone Cells - pathology | Metabolome - drug effects | Signal Transduction - drug effects | Neoplasm Metastasis - pathology | Protein Kinase Inhibitors - therapeutic use | Melanoma - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Pharmaceutical research | Care and treatment | Oncology, Experimental | Dosage and administration | Research | Drug therapy | Drug resistance | Antineoplastic agents | Tumors | Cancer | Melanoma | Mutation | Metastasis | Kinases | Cancer therapies
Journal Article
Journal Article
Journal of controlled release, ISSN 0168-3659, 2010, Volume 141, Issue 2, pp. 137 - 144
.... In this study, we investigated the anticancer efficacy of doxorubicin in combination with photodynamic therapy using methylene blue in a drug-resistant mouse tumor model... 
Nanoparticles | Chemotherapy | Reactive oxygen species | Drug efflux | Drug resistance | Photosensitizer | Adenocarcinoma - pathology | Antibiotics, Antineoplastic - pharmacology | Apoptosis - drug effects | Methylene Blue - metabolism | Dioctyl Sulfosuccinic Acid - chemistry | Microvessels - pathology | Drug Resistance, Neoplasm | Doxorubicin - chemistry | Mammary Neoplasms, Experimental - metabolism | Photochemotherapy | Drug Carriers | Adenocarcinoma - metabolism | Antibiotics, Antineoplastic - chemistry | Biological Transport | Time Factors | Mammary Neoplasms, Experimental - pathology | Drug Compounding | Female | Mammary Neoplasms, Experimental - blood supply | Doxorubicin - metabolism | Glucuronic Acid - chemistry | Doxorubicin - administration & dosage | Mammary Neoplasms, Experimental - drug therapy | Microvessels - drug effects | Hexuronic Acids - chemistry | Methylene Blue - pharmacology | Adenocarcinoma - drug therapy | Chemistry, Pharmaceutical | Adenocarcinoma - blood supply | Antibiotics, Antineoplastic - administration & dosage | Methylene Blue - administration & dosage | Animals | Alginates - chemistry | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Antibiotics, Antineoplastic - metabolism | Methylene Blue - chemistry | Doxorubicin - pharmacology | Anthracyclines | Oncology, Experimental | Research | Polysaccharides | Surface active agents | Analysis | Pharmacy | Drug therapy, Combination | Drug therapy | Cancer | Dyes and dyeing
Journal Article
International journal of nanomedicine, ISSN 1178-2013, 2017, Volume 12, pp. 2689 - 2702
..., such as radiation therapy, surgical operation, stem cell therapy and hyperthermia, as well as pharmacological intervention, including immunotherapy, chemotherapy, and hormone... 
Anthocyanin | Tumor | Malignancy | Natural products | Flavonoid | malignancy | NATURAL PHENOLIC-COMPOUNDS | ADENOCARCINOMA CELLS | NANOSCIENCE & NANOTECHNOLOGY | DRUG-RESISTANCE | KAPPA-B | natural products | NANOPARTICLES | IN-VITRO | ANTICANCER | NANO-CURCUMIN | tumor | PHARMACOLOGY & PHARMACY | flavonoid | anthocyanin | MEDICINAL-PLANTS | CYTOTOXICITY | Stilbenes - administration & dosage | Antioxidants - chemistry | Nanocomposites - chemistry | Nanoparticles - chemistry | Humans | Polyphenols - pharmacology | Biological Availability | Catechin - administration & dosage | Stilbenes - chemistry | Antineoplastic Agents - administration & dosage | Stilbenes - pharmacology | Curcumin - administration & dosage | Antineoplastic Agents - pharmacology | Catechin - pharmacology | Curcumin - pharmacology | Antioxidants - pharmacology | Antineoplastic Agents - chemistry | Neoplasms - drug therapy | Quercetin - pharmacology | Polyphenols - chemistry | Catechin - analogs & derivatives | Nanoparticles - administration & dosage | Drug Delivery Systems - methods | Polyphenols - administration & dosage | Catechin - chemistry | Nanocomposites - administration & dosage | Drugs | Drug delivery systems | Research | Properties | Vehicles | Nanoparticles | Prevention | Complications and side effects | Polyphenols | Physiological aspects | Dosage and administration | Drug therapy | Cancer | Phytochemicals | Polyethylene glycol | Polylactic acid | Tumors | polyphenols | nanoformulation | cancer
Journal Article
Nature communications, ISSN 2041-1723, 2017, Volume 8, Issue 1, pp. 1136 - 11
Journal Article
International journal of experimental and clinical chemotherapy, ISSN 0933-0453, 1988
Journal
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 976 - 983
Journal Article
Journal Article
Immunology and Cell Biology, ISSN 0818-9641, 2008, Volume 86, Issue 3, pp. 277 - 288
Bovine lactoferrin (bLf), an iron‐containing natural defence protein found in bodily secretions, has been reported to inhibit carcinogenesis and the growth of... 
iron‐saturated lactoferrin | tumour eradication | immunosuppression | anaemia | bovine lactoferrin | cancer chemotherapy | Bovine lactoferrin | Immunosuppression | Cancer chemotherapy | Anaemia | Iron-saturated lactoferrin | Tumour eradication | iron-saturated lactoferrin | IMMUNE-RESPONSE | IFN-GAMMA | NECROSIS-FACTOR-ALPHA | IMMUNOLOGY | CELL BIOLOGY | CYCLOPHOSPHAMIDE-TREATED MICE | NITRIC-OXIDE | TNF-ALPHA | ANTITUMOR IMMUNITY | ORALLY-ADMINISTERED LACTOFERRIN | ESTABLISHED TUMORS | Immunohistochemistry | Neoplasm Transplantation | Adjuvants, Immunologic - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Melanoma, Experimental - diet therapy | Melanoma, Experimental - drug therapy | Carcinoma, Lewis Lung - immunology | Carcinoma, Lewis Lung - blood supply | Lactoferrin - administration & dosage | Lymphoma - drug therapy | Lactoferrin - immunology | Melanoma, Experimental - immunology | Cattle | Cytotoxicity, Immunologic - drug effects | Melanoma, Experimental - blood supply | Iron - chemistry | Mice, Inbred C57BL | Lymphoma - immunology | Antineoplastic Combined Chemotherapy Protocols - immunology | Carcinoma, Lewis Lung - drug therapy | Lactoferrin - chemistry | Animals | Neovascularization, Pathologic - drug therapy | Mice | Carcinoma, Lewis Lung - diet therapy | Dietary Supplements | Lymphoma - diet therapy | Adjuvants, Pharmaceutic - administration & dosage | Drug Resistance, Neoplasm - drug effects | Melanoma, Experimental, drug therapy | Drug Resistance, Neoplasm, drug effects | Carcinoma, Lewis Lung, diet therapy | Carcinoma, Lewis Lung, immunology | Lactoferrin, immunology | Cytotoxicity, Immunologic, drug effects | Melanoma, Experimental, immunology | Carcinoma, Lewis Lung, blood supply | Lymphoma, immunology | Carcinoma, Lewis Lung, drug therapy | Melanoma, Experimental, diet therapy | Lactoferrin, administration and dosage | Lymphoma, diet therapy | Antineoplastic Combined Chemotherapy Protocols, administration and dosage | Lymphoma, drug therapy | Adjuvants, Immunologic, administration and dosage | Adjuvants, Pharmaceutic, administration and dosage | Neovascularization, Pathologic, drug therapy | Iron, chemistry | Melanoma, Experimental, blood supply | Lactoferrin, chemistry | Antineoplastic Combined Chemotherapy Protocols, immunology | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 2018, Volume 558, Issue 7711, pp. 605 - 609
Reprogramming of mRNA translation has a key role in cancer development and drug resistance... 
CELLS | MELANOMA | INHIBITION | TRANSFER-RNAS | KINASE | IMPROVED SURVIVAL | MUTATIONS | HUMAN CANCER | VEMURAFENIB | RIBOSOME | MULTIDISCIPLINARY SCIENCES | Phosphorylation | Humans | Melanoma, Experimental - drug therapy | Male | Uridine - genetics | RNA, Messenger - metabolism | Vemurafenib - therapeutic use | Melanoma - genetics | RNA, Transfer - genetics | Carrier Proteins - chemistry | Female | Codon - genetics | Codon - drug effects | RNA, Transfer - chemistry | Uridine - chemistry | Signal Transduction | RNA, Transfer - metabolism | RNA, Messenger - genetics | Melanoma, Experimental - pathology | Melanoma - pathology | Mice, SCID | Vemurafenib - pharmacology | Zebrafish - genetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Mechanistic Target of Rapamycin Complex 2 - metabolism | Drug Resistance, Neoplasm - genetics | Animals | Carrier Proteins - metabolism | Melanoma, Experimental - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Mice, Inbred NOD | Protein Biosynthesis - drug effects | Uridine - metabolism | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Codon | Oncology, Experimental | Melanoma | Research | Genetic translation | Cancer | Enzymes | Physiological aspects | Development and progression | Protein biosynthesis | Transfer RNA | Short term | Therapy | Transformation | Genomes | mRNA | Kinases | Proteins | Signal transduction | Translation | Cell survival | tRNA | MAP kinase | Pharmacology | Decoding | Metabolism | Gene expression | Chemical compounds | Survival | Molecular chains | 1-Phosphatidylinositol 3-kinase | Signaling | Molecular modelling | Protein synthesis | Uridine | Glycolysis | Mutation
Journal Article